Millennium Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,780,068
| Closed | -$42.5M | – | 7463 |
|
|
2021
Q1 | $42.5M | Buy |
1,780,068
+1,751,893
| +6,218% | +$32.6M | 0.03% | 572 |
|
|
2020
Q4 | $411K | Sell |
28,175
-895,310
| -97% | -$11.9M | ﹤0.01% | 4351 |
|
|
2020
Q3 | $13.1K | Sell |
923,485
-1,210,037
| -57% | -$18.5M | 0.02% | 1050 |
|
|
2020
Q2 | $31.4M | Buy |
2,133,522
+1,267,140
| +146% | +$12.9M | 0.04% | 493 |
|
|
2020
Q1 | $3.57M | Buy |
866,382
+756,322
| +687% | +$3.55M | 0.01% | 1597 |
|
|
2019
Q4 | $529K | Sell |
110,060
-337,661
| -75% | -$1.86M | ﹤0.01% | 3352 |
|
|
2019
Q3 | $2.71M | Sell |
447,721
-99,542
| -18% | -$621K | ﹤0.01% | 2241 |
|
|
2019
Q2 | $3.55M | Buy |
547,263
+83,596
| +18% | +$589K | 0.01% | 2045 |
|
|
2019
Q1 | $3.29M | Buy |
463,667
+419,719
| +955% | +$2.76M | ﹤0.01% | 2058 |
|
|
2018
Q4 | $214K | Sell |
43,948
-587,496
| -93% | -$3.06M | ﹤0.01% | 3372 |
|
|
2018
Q3 | $4.64M | Sell |
631,444
-110,308
| -15% | -$809K | 0.01% | 1860 |
|
|
2018
Q2 | $4.73M | Buy |
741,752
+680,882
| +1,119% | +$4.5M | 0.01% | 1848 |
|
|
2018
Q1 | $331K | Sell |
60,870
-543,217
| -90% | -$2.7M | ﹤0.01% | 3177 |
|
|
2017
Q4 | $2.52M | Sell |
604,087
-865,347
| -59% | -$5.21M | ﹤0.01% | 2144 |
|
|
2017
Q3 | $14.2M | Buy |
1,469,434
+290,343
| +25% | +$3.02M | 0.02% | 1002 |
|
|
2017
Q2 | $13.9M | Buy |
1,179,091
+298,152
| +34% | +$3.81M | 0.02% | 865 |
|
|
2017
Q1 | $11.3M | Buy |
880,939
+2,524
| +0.3% | +$30.4K | 0.02% | 959 |
|
|
2016
Q4 | $10.8M | Buy |
878,415
+321,477
| +58% | +$3.82M | 0.02% | 884 |
|
|
2016
Q3 | $6.57M | Buy |
+556,938
| New | +$5.38M | 0.01% | 1170 |
|
|
2016
Q1 | – | Sell |
-42,991
| Closed | -$334K | – | 3801 |
|
|
2015
Q4 | $334K | Sell |
42,991
-114,391
| -73% | -$879K | ﹤0.01% | 2860 |
|
|
2015
Q3 | $1.24M | Sell |
157,382
-13,651
| -8% | -$126K | ﹤0.01% | 2175 |
|
|
2015
Q2 | $1.55M | Sell |
171,033
-197,993
| -54% | -$2M | ﹤0.01% | 2056 |
|
|
2015
Q1 | $4.79M | Sell |
369,026
-114,079
| -24% | -$1.49M | 0.01% | 1434 |
|
|
2014
Q4 | $6.58M | Buy |
483,105
+96,214
| +25% | +$1.08M | 0.01% | 1214 |
|
|
2014
Q3 | $3.47M | Buy |
386,891
+313,339
| +426% | +$3.37M | 0.01% | 1505 |
|
|
2014
Q2 | $995K | Sell |
73,552
-243,930
| -77% | -$2.54M | ﹤0.01% | 2207 |
|
|
2014
Q1 | $3.16M | Buy |
317,482
+292,482
| +1,170% | +$3.63M | 0.01% | 1477 |
|
|
2013
Q4 | $332K | Buy |
+25,000
| New | +$304K | ﹤0.01% | 2980 |
|
Millennium Management's GNMK Position: Q2 2021 in Review
Millennium Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,780,068 shares — an estimated $42.5M sold.
Millennium Management first reported a position in GNMK in Q4 2013 and held it in 28 quarters. The position peaked at $42.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Millennium Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Millennium Management sold 1,780,068 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $42.5M.
- Millennium Management first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 28 quarters.
- Millennium Management's GenMark Diagnostics, Inc position peaked at $42.5M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.